about
Circadian Metabolomics in Time and Space.Circadian MicroRNAs in Cardioprotection.The Ink4a/Arf locus operates as a regulator of the circadian clock modulating RAS activity.Ticking time bombs: connections between circadian clocks and cancer.Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.Community effort endorsing multiscale modelling, multiscale data science and multiscale computing for systems medicine.The tumor circadian clock: a new target for cancer therapy?Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy.In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.Brain Activity during Methamphetamine Anticipation in a Non-Invasive Self-Administration Paradigm in Mice.Relevance of a Mobile Internet Platform for Capturing Inter- and Intrasubject Variabilities in Circadian Coordination During Daily Routine: Pilot Study.The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming.Cancer metabolism gets physical.Chronotherapy with defective circadian clock?The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal CancerHigh-accuracy determination of internal circadian time from a single blood sampleCircadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer
P2860
Q38661360-372982C4-F1D2-4073-8C2A-10981C4536BCQ39430271-D43F6D04-721B-4CCE-AD4E-EB7136BFE420Q45943215-BE6BFEC6-64DE-4D1F-A526-1D567FFBF25CQ47130821-5A4FF01D-6EFD-46FD-BE25-B7A3A158FCD2Q47162410-21324DEE-0FAE-430B-B787-8B6D5BE67A80Q47343098-2EC7A8CF-6DE4-4105-940B-043CFF10E40BQ47571482-F12C0279-86BD-439D-887C-9C7016EA0559Q49315568-4C050B63-C028-4A18-A18B-44F6C1411F42Q49923401-34265691-7B8C-4EFE-A8D2-0C39F52D9353Q50045758-3DFEA2A5-1978-4BCE-A07D-EAB8DE77993AQ52362144-144F616C-69A7-42B5-9F70-78846FE25F63Q52597446-0F56F3CD-6BF3-4BE5-96A6-B827FFE1D8CFQ52692013-F8BC643D-1E34-4CF3-9847-69313533B232Q52727400-65AD33A7-359B-4092-99BD-CFF2C985810BQ54945775-FBFA571E-A0AE-4207-B020-6C72D5262C10Q55021535-80C55C14-53E8-493C-8D95-1FA3FDB97959Q55301481-7E751D98-96EB-4E9C-B6B0-FDAAA32EC47AQ56958863-28A6BA8D-D3C2-4D1B-A5FF-B57CEB41E139Q56965075-5ADE5A23-1348-4A36-86B5-85AC35963F7AQ58796654-C4E62C9D-4310-45DF-A00D-339403B847AC
P2860
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Systems Chronotherapeutics
@ast
Systems Chronotherapeutics
@en
Systems Chronotherapeutics.
@nl
type
label
Systems Chronotherapeutics
@ast
Systems Chronotherapeutics
@en
Systems Chronotherapeutics.
@nl
prefLabel
Systems Chronotherapeutics
@ast
Systems Chronotherapeutics
@en
Systems Chronotherapeutics.
@nl
P2093
P2860
P356
P1476
Systems Chronotherapeutics
@en
P2093
Annabelle Ballesta
David A Rand
Francis A Lévi
Pasquale F Innominato
P2860
P304
P356
10.1124/PR.116.013441
P50
P577
2017-04-01T00:00:00Z